OpenToolslogo
ToolsExpertsSubmit a Tool
AdvertiseLearn AI
  1. home
  2. news
  3. tags
  4. health-technology

health technology

9+ articles
AIAI healthcareAI innovationsAlphaFoldBritish Heart Foundation
Loading news...

Related Topics

AIAI healthcareAI innovationsAlphaFoldBritish Heart FoundationCoVFitECGEVEscapeElon MuskFDA approval

Most Read

1
Samsung Galaxy Watch Gets a Sneak Peek: Meet the GeminiMan Wellness Companion App!
2
Elizabeth Holmes May Be Down, But Is Haemanthus a Sign of Her Return?
3
Hong Kong's AI Healthcare Revolution: Centralized Data Could Be the Game Changer
4
Pathos and Addepar Lead the Charge in $2.3 Billion Week for U.S. Startups!
5
Elon Musk's Supercomputer Initiative: A Breath of Fresh (or Not) Air for AI and Asthma

Stay in the loop

Weekly updates on tools, models, and the companies building them.

Subscribe free

Footer

Company name

The right AI tool is out there. We'll help you find it.

LinkedInX

Knowledge Hub

  • News
  • Resources
  • Newsletter
  • Blog
  • AI Tool Reviews
  • YouTube Summary
  • YouTube Transcript Generator

Industry Hub

  • AI Companies
  • AI Tools
  • AI Models
  • MCP Servers
  • AI Tool Categories
  • Top AI Use Cases

For Builders

  • Submit a Tool
  • Experts & Agencies
  • Advertise
  • Compare Tools
  • Favourites

Legal

  • Privacy Policy
  • Terms of Service

© 2026 OpenTools - All rights reserved.

Samsung Galaxy Watch Gets a Sneak Peek: Meet the GeminiMan Wellness Companion App!

A leaked app, GeminiMan Wellness Companion, is set to redefine wellness tracking on Samsung Galaxy Watches. Discovered by well-known leaker Dante63, this app introduces ECG recording directly on the watch, enhancing Samsung's health ecosystem. This innovative app marks a significant leap in wearable health, although its official release remains mysteriously under wraps.

Apr 12
Samsung Galaxy Watch Gets a Sneak Peek: Meet the GeminiMan Wellness Companion App!

Elizabeth Holmes May Be Down, But Is Haemanthus a Sign of Her Return?

Despite serving an 11-year prison sentence for the Theranos scandal, Elizabeth Holmes seems to have a lingering influence on Haemanthus, a new blood-testing startup led by her partner, Billy Evans. While she has no official ties, the echoes of Theranos are evident, sparking concerns about her role in a potential technological resurrection.

Sep 14
Elizabeth Holmes May Be Down, But Is Haemanthus a Sign of Her Return?

Hong Kong's AI Healthcare Revolution: Centralized Data Could Be the Game Changer

Hong Kong's massive pool of patient data positions it as a potential leader in AI healthcare. The city could leverage its centralized healthcare system, which has amassed data since the 1990s from over 11 million patients, to develop cutting-edge AI applications. These applications may transform diagnostics, personalized treatments, and drug discovery. However, this comes with ethical considerations regarding data privacy and consent.

Jun 16
Hong Kong's AI Healthcare Revolution: Centralized Data Could Be the Game Changer

Pathos and Addepar Lead the Charge in $2.3 Billion Week for U.S. Startups!

In a remarkable display of sector resilience amidst a downturn, the U.S. startup scene saw seven mega funding rounds exceeding $100 million, led by Pathos and Addepar. This highlights the booming potential and continued investor interest in AI-driven health and fintech innovations.

May 17
Pathos and Addepar Lead the Charge in $2.3 Billion Week for U.S. Startups!

Elon Musk's Supercomputer Initiative: A Breath of Fresh (or Not) Air for AI and Asthma

Elon Musk is reportedly pivoting his focus to supercomputers capable of tackling issues like asthma. This bold move signals Musk's continued ambition to leverage advanced technology for health solutions, prompting discussions on the impact of AI on respiratory conditions and environmental data analysis.

May 7
Elon Musk's Supercomputer Initiative: A Breath of Fresh (or Not) Air for AI and Asthma

Craif Secures $22M to Revolutionize Early Cancer Detection with AI-Powered miRNA Tech

Japanese startup Craif is making waves as it secures $22 million in Series C funding to bring its groundbreaking AI-driven cancer detection platform to the U.S. market. Using microRNA (miRNA) from urine, Craif's miSignal test offers a non-invasive alternative to traditional methods, aiming to detect seven types of cancer early on. With plans to expand detection capabilities and explore other applications, this innovative platform is on track for U.S. trials by 2029, with FDA approval on the horizon.

Apr 28
Craif Secures $22M to Revolutionize Early Cancer Detection with AI-Powered miRNA Tech

AI-Powered Databases Revolutionize Alzheimer's Drug Discovery

AI-powered databases are speeding up the discovery of Alzheimer's drugs by streamlining data analysis, helping researchers identify potential drug targets more efficiently. No new drugs have surfaced solely from this tech yet, but the acceleration in understanding and testing represents a promising future for Alzheimer's treatment.

Mar 24
AI-Powered Databases Revolutionize Alzheimer's Drug Discovery

AI Predicts Viral Evolution: The Future of Pandemic Preparedness

Dive into the world of AI as it takes on the challenge of predicting viral evolution, specifically SARS-CoV-2. Discover how AI models like CoVFit and EVEscape, powered by tools such as AlphaFold, are beginning to accurately forecast potential viral mutations that could dominate in the short term. Learn how the wealth of SARS-CoV-2 genomic data is aiding this groundbreaking research and explore the potential—and current limitations—of these predictions in shaping future vaccine and antiviral strategies.

Jan 9
AI Predicts Viral Evolution: The Future of Pandemic Preparedness

AI Steps Up to the Plate in Detecting Atrial Fibrillation Early

In a groundbreaking trial, a cutting-edge AI tool is being tested to identify atrial fibrillation (AF) before symptoms arise. This initiative, happening in West Yorkshire, UK, is supported by the British Heart Foundation and Leeds Hospitals Charity. The AI tool analyzes GP records to spot AF risk factors such as age, sex, ethnicity, and existing health conditions, potentially setting a new standard for preventative heart care. This trial could revolutionize early AF detection and reduce stroke risks, offering a promising future for heart health diagnostics.

Dec 31
AI Steps Up to the Plate in Detecting Atrial Fibrillation Early